Kathryn Romano - Feb 26, 2022 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Chief Accounting Officer
Signature
/s/ Kathryn Romano
Stock symbol
KRYS
Transactions as of
Feb 26, 2022
Transactions value $
-$92,000
Form type
4
Date filed
3/1/2022, 08:25 PM
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Tax liability -$92K -1.47K -7.51% $62.50 18.1K Feb 26, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +50K $0.00 50K Feb 28, 2022 Common Stock 50K $63.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2022.
F2 The closing price on February 25, 2022 of the Company's common stock on NASDAQ.
F3 The option vests in four equal annual installments beginning on February 28, 2023.